Company: BSX
Filing Date: 2025-05-01
Form Type: 10-Q
Source: 0000885725-25-000026
Chunk: 98

Company: BOSTON SCIENTIFIC CORP
Filing Date: 2025-05-01
Form: 10-Q
Item: Part I, Item 8
Chunk 98
---
31, 2025. Strategic InvestmentsThe aggregate carrying amount of our strategic investments was comprised of the following:As of(in millions)March 31, 2025December 31, 2024Equity method investments$358 $278 Measurement alternative investments(1, 2)297 277 $655 $555 (1) Measurement alternative investments are privately-held equity securities without readily determinable fair values that are measured at cost less impairment, if any, adjusted to fair value for any observable price changes in orderly transactions for the identical or a similar investment of the same issuer, recognized in Other, net within our accompanying unaudited consolidated statements of operations.

11

(2) Includes publicly-held equity securities measured at fair value with changes in fair value recognized in Other, net within our accompanying unaudited consolidated statements of operations.These investments are classified as Other long-term assets within our accompanying unaudited consolidated balance sheets, in accordance with GAAP and our accounting policies. 

As of March 31, 2025, the cost of our aggregated equity method investments exceeded our share of the underlying equity in net assets by $374 million, which represents amortizable intangible assets, in-process research and development (IPR&D), goodwill and deferred tax liabilities. 

NOTE C – GOODWILL AND OTHER INTANGIBLE ASSETS The gross carrying amount of goodwill and other intangible assets and the related accumulated amortization for intangible assets subject to amortization and accumulated goodwill impairment charges are as follows:As of March 31, 2025As of December 31, 2024(in millions)Gross Carrying AmountAccumulated Amortization/ Write-offsGross Carrying AmountAccumulated Amortization/ Write-offsTechnology-related$14,406 $(8,799)$14,327 $(8,605)Patents481 (380)481 (381)Other intangible assets2,406 (1,643)2,380 (1,612)Amortizable intangible assets$17,293 $(10,821)$17,188 $(10,598)    Goodwill$27,240 $(9,900)$26,989 $(9,900)IPR&D$94 $94 Indefinite-lived intangible assets$94 $94 The increase in our balance of goodwill is related primarily to our acquisition of Cortex in the first quarter of 2025. The following represents a roll forward